Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042
20 mars 2024 08h00 HE
|
Lumos Pharma, Inc.
AUSTIN, Texas, March 20, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric Growth Hormone Deficiency (PGHD)...
CARBOGEN AMCIS announces successful ANVISA audit of its facility in China
19 mars 2024 13h58 HE
|
CARBOGEN AMCIS INNOVATIONS AG
CARBOGEN AMCIS announces successful completion of its first Brazilian Regulatory Authority Agency (ANVISA) routine inspection of its Shanghai facility
CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)
19 mars 2024 10h00 HE
|
Charm Therapeutics
PRESS RELEASE CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB) LONDON – 19 March 2024 -- CHARM Therapeutics (“CHARM”, “The Company”), a 3D deep-learning research company...
Pharmaceutical Packaging Market Estimated to Reach $269.9 billion by 2028 Globally, at a CAGR of 15.4%, says MarketsandMarkets™
19 mars 2024 08h30 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, March 19, 2024 (GLOBE NEWSWIRE) -- The Global Pharmaceutical Packaging Market size is projected to reach USD 269.9 billion by 2028 from USD 132.0 billion in 2023, at a CAGR of 15.4% during...
RS BioTherapeutics Selected for Presentation at American Thoracic Society’s 2024 Respiratory Innovation Summit
18 mars 2024 11h30 HE
|
RS BioTherapeutics
RS BioTherapeutics is pleased to announce that its submission has been selected for a poster presentation at the 2024 Respiratory Innovation Summit
SHAREHOLDER ALERT: Barrack, Rodos & Bacine Notifies Shareholders of Anavex Life Sciences Securities Class Action Lawsuit
18 mars 2024 09h47 HE
|
Barrack Rodos & Bacine
PHILADELPHIA, March 18, 2024 (GLOBE NEWSWIRE) -- The law firm of Barrack, Rodos & Bacine announces that a class action lawsuit has been filed on behalf of investors in Anavex Life Sciences...
Sanofi: Informations relatives au nombre de droits de vote et d'actions - FEVRIER 2024
15 mars 2024 15h04 HE
|
Sanofi - Aventis Groupe
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés...
Sanofi: Information concerning the total number of voting rights and shares - February 2024
15 mars 2024 15h04 HE
|
Sanofi - Aventis Groupe
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...
Supercharge Your Health: Unveiling the Omega-3 Market Booms
15 mars 2024 09h30 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, March 15, 2024 (GLOBE NEWSWIRE) -- Omega-3 Market Growth Projection The Omega-3 market refers to the commercial landscape involving products containing omega-3 fatty acids, which are...
Pharmaceuticals Licensing Agreements Analysis Report 2024 with a Directory of Deals Signed Since 2019
13 mars 2024 09h38 HE
|
Research and Markets
Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Licensing Deals in Pharmaceuticals 2019-2024" report has been added to ResearchAndMarkets.com's offering. Licensing Deals in Pharmaceuticals...